Introduction
============

*Acinetobacter baumannii* is an emerging Gram-negative opportunistic pathogen, causing serious hospital-acquired infections ([@B2]). These bacteria are well adapted to survive in hospital environment such as intensive care units, burn wards, and field hospitals ([@B55]). During the last decade, several highly successful multidrug-resistant *A. baumannii* clonal lineages have spread in clinical settings worldwide causing difficult to treat hospital outbreaks ([@B23]). *A. baumannii* is known for its ability to withstand harsh environmental conditions such as prolonged periods of dryness, disinfectants, and antibiotic treatment ([@B28]; [@B4]; [@B46]).

Bacterial type II toxin-antitoxin (TA) systems are the most ubiquitous among six types of prokaryotic toxin-antitoxin systems (TAs), known to date ([@B5]; [@B47]; [@B54]). They are encoded on the low copy plasmids or chromosomes and code for two proteins, one of which (toxin) is toxic to the cell, whereas the other (antitoxin) neutralizes its toxicity by forming strong protein--protein complex, which is non-harmful. Upon release from the complex, the toxin acts within the cell by interfering with essential processes, such as protein ([@B11]; [@B18]) or DNA synthesis ([@B20]), cell wall synthesis ([@B45]), and cell division ([@B41]). The toxin action results in a rapid cell growth arrest or even leads to cell death ([@B47]). The majority of toxins from type II systems, characterized to date, are endoribonucleases ([@B9]), which, if not neutralized by its cognate antitoxin protein, cleave mRNAs at specific sequences either within or outside the ribosome and inhibit translation ([@B5]). The plasmid-borne type II TAs often function as plasmid stabilization elements by allowing growth of the cells that inherit plasmid with the TA system upon segregation, whereas cells that have lost plasmid are killed by more stable toxin after the more labile antitoxin is degraded by proteases ([@B14]; [@B22]). The biological role of chromosomally encoded type II systems is not clearly elucidated yet. The proposed functions of type II TAs range from viewing them as selfish DNA, anti-addiction elements to stress-responsive genes, which can regulate bacterial growth and survival adapting to various environmental changes ([@B39]; [@B66]; [@B53]). The TA systems can adjust the metabolic processes at a large scale, such as shutting down protein synthesis and switching to a dormant cellular state ([@B31]; [@B34]).

Genome analysis has shown a wide variety of TA modules in pathogenic species ([@B40]; [@B35]). The role of TAs in the life of bacterial pathogens is now beginning to be explored ([@B15]; [@B31]; [@B34]; [@B36]). Recent reports have demonstrated the significance of TAs in the stabilization of virulence plasmids in *Shigella* ([@B43]) and *Salmonella enterica* ([@B37]), superintegron in *Vibrio cholerae* ([@B26]), also in the promoting of *S. enterica* persister formation ([@B6]; [@B27]) and in mediating the transcriptional response to environmental cues in *Helicobacter pylori* and *Brucella abortus* ([@B21]; [@B3]).

We have recently shown that type II HigBA TA system is one of the most prevalent plasmid-borne TA systems in *A. baumannii* isolates of clinical origin. It is encoded by the *higBA*~Ab~ operon, where *higB*~Ab~ toxin gene (357 bp) precedes *higA*~Ab~ antitoxin (303 bp) ([@B29]; [@B64]). *higBA*~Ab~ locus was also found to be encoded by the newly observed ubiquitous *A. baumannii* 11 kb plasmid pAB120. Plasmid carries two copies of *bla*~OXA-72~ genes, conferring resistance to carbapenems, a broad spectrum β-lactam antibiotics class, which is used to treat *A. baumannii* infections ([@B48]; Supplementary Figure [S1](#SM5){ref-type="supplementary-material"}). Here we report characterization of *A. baumannii* type II TA system, by demonstrating that *higBA* locus is represented in *A. baumannii* by two functional variants, named *higBA1*~Ab~ and *higBA2*~Ab~. The *higBA2*~Ab~ is encoded on pAB120 plasmid and was further thoroughly characterized. We demonstrate that HigB2~Ab~ toxin acts as a ribonuclease and forms an unusually large complex with the antitoxin. Both HigA2~Ab~ and the HigBA2~Ab~ protein complex transcriptionally autoregulate their own operon. We show that *higBA2*~Ab~ represents a stress responsive TA locus, which also possesses plasmid stabilization ability.

Materials and Methods {#s1}
=====================

Bacterial Strains and Growth Conditions
---------------------------------------

*Escherichia coli* and *Acinetobacter* strains were grown in LB at 37°C with appropriate antibiotics added (ampicillin 100 μg/mL, meropenem 8 μg/mL, gentamicin 10 μg/mL, kanamycin 50 μg/mL, and chloramphenicol 30 μg/mL), unless otherwise indicated. The strains and plasmids used in the study are described in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. *A. baumannii* was transformed with plasmid pAB120 variants by electroporation, and selected on LB containing meropenem. Minimal inhibitory concentration (MIC) values were detected as described ([@B67]).

Plasmid Construction
--------------------

Gene cloning procedures were performed using high-fidelity Phusion polymerase (Thermo Fisher Scientific), cleavage with restriction enzymes and ligation was performed according manufacturers recommendations (New England Biolabs, Thermo Fisher Scientific). All final constructs were verified by sequencing. pAB120ΔhigBA: to introduce *higBA2*~Ab~ deletion to pAB120, primers described in Supplementary Table [S2](#SM2){ref-type="supplementary-material"} were used for inverse PCR ([@B25]). The resulting PCR product was cleaved with NcoI and ligated. The deletion of *higBA2*~Ab~ was confirmed by PCR. pAcORI^∗^higBA: a derivative of the plasmid pWH1266 ([@B24]; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), exhibiting faulty inheritance in *Acinetobacter* sp. was constructed. pAcORI^∗^ plasmid contained pUC19 backbone with introduced gentamicin resistance gene and a defective *Acinetobacter calcoaceticus* ORI from pWH1266, amplified using primers listed in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}. *higBA2*~Ab~ TA system from pAB120, together with predicted promoter region, was then cloned to pAcORI^∗^ using primers in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}. BACTH constructs: for T18 and T25 fusions plasmids pUT18 and pKNT25 (Euromedex BACTH System Kit) were used. *higB2*~Ab~, *higA2*~Ab~, *relB*~Ab~, *relE*~Ab~ genes were PCR-amplified using primer pairs described in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}. pAB120 plasmid was used as a template for *higBA2*~Ab~ gene amplification, while for *relBE*~Ab~ *A. baumannii* clinical (35, ECII) strain was used ([@B29]). Both toxins and antitoxins were N-terminally fused to appropriate Cya domains. Protein expression plasmids: for protein purification, *higBA2*~Ab~ operon was cloned to pET28b protein expression vector, fusing the antitoxin (C-terminally) or the toxin (N-terminally) with his-tag (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). To construct plasmids containing TEV cleavage sites, the thrombin recognition site in the plasmid was replaced to TEV site by inverse PCR using primers listed in Supplementary Table [S2](#SM2){ref-type="supplementary-material"} to generate pET-His6-TEV-HigB-HigA plasmid. For pET-HigB-His6-TEV-HigA, TEV site and His-tag was first removed from previous plasmid and then added to the N-terminus of *higA2*~Ab~. Constructs for promoter repression assay: pPROBE'-gfp vectors were constructed by inserting PCR amplified predicted promoter DNA sequences (200 bp in length upstream of *higB2*~Ab~ or *higA2*~Ab~ genes; primers indicated in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}) upstream of *gfp* gene. *higBA2*~Ab~ and *higA2*~Ab~ genes were cloned to pBAD24 under arabinose inducible promoter (primers indicated in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). pBAD-higBpAB120 and pUHEcat-higApAB120 for kill-rescue assay: the plasmids were constructed as described elsewhere ([@B29]).

Bacterial Adenylate Cyclase Two Hybrid System (BACTH) Assay
-----------------------------------------------------------

Five independent clones, with compatible toxin and antitoxin containing pKNT25 and pUT18 vectors were grown in LB for 16 h, then the cultures of the five clones were mixed and 5 μL of the mix was spotted on LB agar plates containing appropriate antibiotics, 100 μg/mL IPTG and 100 μg/mL X-Gal. The plates were incubated for 24 h at 30°C.

Purification of HigBA2~Ab~ Protein Complex
------------------------------------------

For purification of His-HigBA2 and HigBA2-His protein complexes, plasmids pET-His-HigBA or pET-HigBA-His, were introduced into *E. coli* strain BL21 (DE3) (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) and the expression of protein complex induced by incubation with 1 mM IPTG for 4 h during mid-logarithmic phase. Cells were collected by centrifugation for 10 min at 4°C 5500 g, bacterial pellets were resuspended in lysis buffer (20 mM NaH~2~PO~4~ pH 7.4, 500 mM NaCl, 20 mM imidazole) and lysed by sonication. Lysate was centrifuged for 10 min at 4°C 13000 g to remove cell debris. The protein complexes were purified from soluble fraction by affinity chromatography, using 1 mL HisTrapHP^TM^ nickel-Sepharose column (GE Healthcare), equilibrated with 20 mM NaH~2~PO~4~ pH 7.4, 500 mM NaCl, 20 mM imidazole buffer. After loading the protein lysate, the column was washed with the same buffer for column volumes followed by 10 volumes of wash buffer (20 mM NaH~2~PO~4~ pH 7.4, 500 mM NaCl, 50 mM imidazole) to remove impurities. Proteins were eluted by linear gradient using buffer 20 mM NaH~2~PO~4~ pH 7.4, 500 mM NaCl, 500 mM imidazole. The eluted fractions were desalted using Sephadex G--25 (GE Healthcare) column, exchanging the buffer to 20 mM NaH~2~PO~4~ pH 7.2, 300 mM NaCl. Eluted proteins were analyzed by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS--PAGE), stained with Coomassie Brilliant Blue. To generate tag-less complex, His-TEV-HigBA2 proteins were incubated with TEV protease at a molar ratio of 1 to 100 overnight at room temperature.

Protein Complex Size Determination by Size-Exclusion Chromatography
-------------------------------------------------------------------

Purified His-HigBA2 and HigBA2-His complexes were analyzed by FPLC gel filtration chromatography using Superose 12 10/300 GL column (GE Healthcare). Column was washed with 20 mM NaH~2~PO~4~ pH 7.2, 300 mM NaCl buffer. Gel filtration flow rate was 0.5 mL/min. The relative quantities of the proteins present in the fractions were determined after SDS--PAGE using Image Lab software (Bio-Rad). The tag-less HigBA2 complex was analyzed by Superdex 200 16/60 column (GE Healthcare), using 50 mM Tris, pH 8.0, 500 mM NaCl buffer. The protein molecular mass standards were thyroglobulin (670 kDa); γ-globulin (158 kDa); bovine serum albumin (66 kDa); ovalbumin (43 kDa); myoglobin (17 kDa); vitamin B12 (1.35 kDa) (Bio-Rad Gel filtration standard 151--1901) and Blue Dextran (GE Healthcare).

Toxin Purification From Protein Complex
---------------------------------------

To separate HigB2 toxin from His-HigBA2 complex, denaturant-induced dissociation of the toxin--antitoxin complex on-column method was used ([@B62]). Briefly, the protein complex was denatured on the affinity column using guanidine HCl buffer (5 volumes of 50 mM Tris, pH 8.0, 500 mM NaCl, 5 M guanidine HCl), followed by renaturing on the resin (5 volumes of 25 mM Tris pH 8.0, 250 mM NaCl, 5% glycerol, followed by 5 volumes of 25 mM Tris pH 8.0, 250 mM NaCl, 1% glycerol). The toxin was eluted with 50 mM Tris pH 8.0, 500 mM NaCl, 200 mM imidazole, then immediately dialyzed to 50 mM Tris--HCl pH 8.0.

RNA Cleavage Analysis *in Vitro*
--------------------------------

Total *A. baumannii* RNA, 5S rRNA and *E. coli* total tRNA were used as substrates for *in vitro* RNA cleavage analysis by HigB2 toxin. The mixtures (20 μL) contained 1.5 μg total RNA or 3 μg of 5S or tRNA in 25 mM Tris--HCl pH 7.8, and 0--1 μM final concentration of His-HigB2 protein. As a control, 1 μM of His-HigBA2 protein complex was added. The mixes were incubated for 30 min at 37°C and fractionated using 2% agarose electrophoresis.

Promoter Activity and Repression Measurements *in Vivo*
-------------------------------------------------------

For promoter activity assays DJ624Δ*ara* cells were transformed with pPROBE'-gfp vectors with or without inserted predicted promoter sequences upstream from *gfp*. Together, pBAD24, pBAD24-HigBA or pBAD24-HigA vectors were co-transformed. Overnight cultures of resulting strains were diluted to optical density at 600 nm (OD~600~) = 0.02 in minimal M9 media with casamino acids, 50 μg/mL kanamycin, 100 μg/mL ampicillin and 0.2% glucose. 1 mL of cultures was grown in glass bottom black 24 well plates (Greiner) in Spectramax microplate reader at 37°C with constant shaking. OD~600~ and fluorescence (excitation 485 nm emission 520 nm) were registered every 15 min. After 3 h of growth 0.2% arabinose was added to induce the protein expression from pBAD24 vectors and measurements were continued for 10 more hours.

Analysis of Gene Expression by qPCR
-----------------------------------

*Acinetobacter baumannii* clinical strain K60 ([@B48]), containing pAB120 plasmid, was grown in LB, to exponential phase (OD~600~ = 1) and to stationary phase (48 h, OD~600~ = 4.5). For stress conditions, the cells were grown in LB with 200 mM 2,20-bipyridine ([@B13]) or in LB with 1 or 2% ethanol to OD~600~ = 1. For antibiotic stress, 1/10 of MIC values for gentamicin and rifampicin (2 and 0.3 μg/mL, respectively) and 1/2 MIC for meropenem (16 μg/mL) was added to exponentially growing cells and incubated for 1 h to a final OD~600~ = 1. Total RNA was isolated, DNA removed and cDNA synthesized as recommended by the kit supplier (Thermo Fisher Scientific). qPCR was performed using primer pairs listed in Supplementary Table [S2](#SM2){ref-type="supplementary-material"} (all primers exhibited 100--103% amplification efficiency at selected concentrations). The changes in gene expression were calculated as ΔΔCt, using *rpoB* as house-keeping gene. At least three biological replicas were performed.

Plasmid Stability Assay
-----------------------

Bacteria containing plasmid of interest were grown in LB containing appropriate antibiotic as an overnight culture (16 h), and then diluted 500-fold to a fresh media without antibiotic. The culture was restarted to a new batch of LB without antibiotic every 12 h. After each inoculation the colony forming units (CFU) of antibiotic resistant (retaining the plasmid encoding resistance) and sensitive bacteria (plasmid lost) was calculated by serial dilutions and plating on LB agar with or without appropriate antibiotic, and plasmid retention was calculated as a percentage of resistant bacteria.

Plasmid Copy Number (PCN) Calculation
-------------------------------------

Plasmid copy number (PCN) was calculated as described elsewhere ([@B49]). Briefly, the bacteria were grown for 24 h without antibiotic pressure, the cells were collected and their lysates used for qPCR, with primers detecting *rep* gene of the pAB120 plasmid and *rpoB* as genome encoded control. Copy number was calculated as PCN = E^ΔCt^ (*E* = 2, if the product amplifies at 100% efficiency, which was the case for the primers used). The experiment was independently repeated 10 times.

Kill-Rescue Assay
-----------------

The assay was performed as previously described ([@B29]). Briefly, *E. coli* BW25113 F' pUHEcat-"antitoxin" pBAD-"toxin" strains were grown in LB medium until the early logarithmic phase (optical density at 600 nm (OD~600~) = 0.1). The culture was then induced with arabinose (0 or 0.02%) and/or IPTG (0, 0.1, and 1 mM). The growth was observed in Tecan Infinite M200 Pro plate reader at 37°C with shaking.

*In Silico* Analysis
--------------------

Cluster of GP49-domain toxin family was prepared as neighbor joining tree ([@B57]) using BLOSUM62 matrix, average distance tree of two major lineages of HigB toxins based on sequence identity as well as alignment of HigB~Ab~ toxins obtained using ClustalW and Jalview 2.10.0b1.

Results
=======

*higBA*~Ab~ System in *A. baumannii* Is Represented by Two Variants
-------------------------------------------------------------------

*Acinetobacter baumannii higBA* module has been classified on the basis of low but significant homology of its predicted GP49-like domain toxin HigB to the RelE/ParE superfamily toxins ([@B29]). Further homology search has shown that the closest GP49-domain homologues of HigB~Ab~ mentioned in the literature are *Mycobacterium tuberculosis* Rv2022c-Rv2021c (also called *higBA2*) and Rv3182-Rv3183 (*higBA3*) TA systems, whose toxins share more than 40% protein sequence identity with HigB~Ab~ (**Figure [1A](#F1){ref-type="fig"}**). Based on the BLAST search, close homologues of HigB~Ab~ (more than 50% sequence identity) are present in other gammaproteobacteria closely related to *Acinetobacter*, such as *Psychrobacter*, as well as various members of *Enterobacteriaceae* family, such as *Klebsiella* (Supplementary Figure [S2](#SM6){ref-type="supplementary-material"}).

![Phylogenetic and homology analysis of *Acinetobacter baumannii* HigB~Ab~. **(A)** Cluster of GP49-domain toxin family within RelE superfamily, represented as neighbor joining tree. Gray box covers all GP49-domain proteins. The full organism names are provided in the Supplementary Material (Supplementary Table [S3](#SM3){ref-type="supplementary-material"}); **(B)** Two major lineages of HigB~Ab~ toxins, represented as average distance tree. All proteins that have more than 1% identical hits in all deposited sequences are shown and their frequency in percentage is provided; **(C)** Alignment of pAB120-borne HigB2~Ab~ ([@B48]) and HigB1~Ab~ ([@B29]) toxin sequences. Identical amino acid residues are outlined in gray boxes. All alignments were prepared as described in Section "Materials and Methods"; **(D--G)** Growth of *Escherichia coli* BW25113F′ harboring components of *higBA*~Ab~ and their combinations. The *E. coli* strains with pUHE-"antitoxin" and pBAD30-"toxin" plasmids were grown until OD~600~ = 0.1 and induced with 0.02% arabinose and/or with 0.1--1 mM IPTG as described in Section "Materials and Methods." The data from three independent experiments are represented, the error bars indicate standard deviation.](fmicb-09-00732-g001){#F1}

Strikingly, BLAST search revealed a variety of amino acid sequences for HigB~Ab~ toxin in *A. baumannii* species. Therefore, we have aligned all *A. baumannii* HigB~Ab~ sequences existing to date and found that they are, in fact, represented by two distinct versions of HigB~Ab~ modules showing around 60% sequence identity (**Figures [1B,C](#F1){ref-type="fig"}**). The most prevalent version is largely conserved (called HigB1~Ab~ further), while the other version of HigB~Ab~ is represented by many sequence variations ranging from 85 to 99% identity (HigB2~Ab~) (**Figure [1B](#F1){ref-type="fig"}**). The *higBA*~Ab~ module found in plasmid pAB120 ([@B48]), which we characterize in this study, represents the less conservative version *higBA2*~Ab~, while the conserved version *higBA1*~Ab~ has been characterized previously as a representative *higBA*~Ab~ module carried by strain 35 in a pilot study of *A. baumannii* TA systems ([@B29]). We were interested whether the two versions of TA systems constitute stand-alone TA modules. Expression of both versions of HigB~Ab~ toxin resulted in an inhibition of *E. coli* growth, and interestingly, co-expression of HigA~Ab~ antitoxin counteracted toxin-mediated growth inhibition regardless the HigA~Ab~ variant used for growth rescue (**Figures [1D](#F1){ref-type="fig"}--[G](#F1){ref-type="fig"}**). This experiment has shown that the components of two TA variants are still able to interact despite 42 and 45% amino acid sequence difference between the toxins and antitoxins of the two groups, respectively. Structure models of both versions of HigB and HigA (Supplementary Figure [S3](#SM7){ref-type="supplementary-material"}) also predicted high similarity of folds, despite some differences at the termini of the proteins. Notably, the pAB120-borne HigBA2~Ab~ pair exhibited more pronounced kill-rescue effect compared to the more conserved HigBA1~Ab~ version (**Figures [1D](#F1){ref-type="fig"}** vs. **[G](#F1){ref-type="fig"}**). These results are in line with the proposed anti-addiction hypothesis ([@B56]), where the conserved but less active HigBA1~Ab~ module could provide evolutionary pressure for the HigBA2~Ab~ lineage.

We then searched for *Acinetobacter* sp. strains having both *higBA*~Ab~ versions in the GenBank sequence database. We were not able to find two distinct versions of *higBA*~Ab~ on the same plasmid or in the same strain. This phenomenon has been reported previously by analysis of identity of bacterial and chromosomal TAs ([@B51]). However, we were able to find two sequenced *Acinetobacter* sp. isolates with copies of *higBA*~Ab~ on several plasmids \[isolates DUT-2 (GenBank accessions CP014652, CP014654, CP014655) and VE-C3 (GenBank accessions NC_010310, NZ_ALIG01000010)\], and five plasmids containing two copies of same version of *higBA*~Ab~ (GenBank accessions CM008888, CP010369, CM001803, NC_010404, NC_025173) (Supplementary Table [S3](#SM3){ref-type="supplementary-material"}). Interestingly, all of them had the less conserved *higBA2*~Ab~ versions. In two cases \[plasmid "unnamed2" from *A. baumannii* strain ZQ1 (Supplementary Table [S3](#SM3){ref-type="supplementary-material"}) and DUT-2 (plasmids CP014652, CP014654)\], both copies of *higBA*~Ab~ were identical, indicating a recent event of duplication. The other cases with two distinct *higBA2*~Ab~ variants had 86 to 88% DNA sequence identity. The presence of two diverse copies of *higBA*~Ab~ in the same bacteria or on a single plasmid could indicate the event of ongoing evolution of the system and its separation into two different TA systems.

HigB2~Ab~ and HigA2~Ab~ Proteins Form Complex
---------------------------------------------

pAB120 plasmid-borne HigBA2~Ab~ and its toxin HigB2~Ab~ shares only low similarity to RelE/ParE type TA toxins. Therefore we asked whether this TA system is and acts as a canonical one. Type II TA systems are known to employ different mechanisms of action and their proteins may form different oligomeric complexes ([@B5]; [@B54]). We asked whether HigB2~Ab~ and HigA2~Ab~ form a physical complex which neutralizes toxicity in a typical way to type II TA systems. For this purpose we employed bacterial adenylate cyclase two hybrid system (BACTH) ([@B30]) and verified that HigB2~Ab~ toxin and HigA2~Ab~ antitoxin directly interact *in vivo* by restoring adenylate cyclase activity (**Figure [2A](#F2){ref-type="fig"}**). Moreover, the *A. baumannii* RelE~Ab~ and RelB~Ab~ proteins \[homologues of well-described RelBE TA system of *E. coli* ([@B29])\], which we used as a control, showed even weaker interaction in comparison to that of HigB2~Ab~ and HigA2~Ab~.

![Analysis of HigB2~Ab~--HigA2~Ab~ protein interaction. **(A)** Two-hybrid analysis of interaction of toxin-antitoxin (TA) components. *E. coli* BTH101 with two plasmids, one encoding Cya-T18 fused to *A. baumanii* antitoxins HigA2~Ab~ or RelB~Ab~, and another encoding Cya-T25 fused to toxins HigB2~Ab~ or RelE~Ab~. The ability of the proteins to interact and reconstitute functional Cya from T25 and T18 was observed as blue colony formation when grown on LB agar with IPTG and X-gal for 24 h; **(B)** Size-exclusion chromatography and SDS--PAGE analysis of His-HigBA2 and HigBA2-His protein complexes. The proteins used for molecular mass standard curve are indicated as black diamonds, empty diamonds indicate the positions of His-HigBA2 and HigBA2-His protein complexes and single His-HigB2 protein and their calculated size; inside box -- 15% SDS--PAGE gel analysis lane 1 -- His-HigB2, lane 2 -- His-HigBA2, lane 3 -- HigBA2-His proteins and complexes after gel filtration; **(C,D)** *E. coli* BL21(DE3) strain, containing pET-HigBA-His **(C)** and pET-His-HigBA **(D)** plasmids were grown to mid-exponential phase and protein expression was induced with 1 mM IPTG for 4 h. Cells were disrupted by sonication and the His-tag containing proteins were purified by affinity chromatography from the soluble fraction as described in Section "Materials and Methods". Proteins were visualized by 15% SDS--PAGE stained with Coomassie Brilliant Blue. M -- protein molecular mass markers (band sizes in kDa are shown on the Left), --/+ cell lysate before and after induction with IPTG, S -- soluble protein fraction after cell disruption, F -- protein purification flow-through fraction, W -- protein purification wash fraction, Elution -- protein purification elution fractions.](fmicb-09-00732-g002){#F2}

To further assess the complex forming ability between *A. baumannii* HigB2~Ab~ and HigA2~Ab~ proteins, we have constructed two versions of the expression vectors encoding *higBA2*~Ab~ operon with HigB2~Ab~ toxin N-terminal His-tag fusion (pET-His-HigBA) and with antitoxin HigA2~Ab~ C-terminal His-tag fusion (pET-HigBA-His). Proteins were expressed in *E. coli* and purified by affinity chromatography as described in Section "Materials and Methods." In both cases HigB2~Ab~ and HigA2~Ab~ proteins co-purified, indicating that they form a strong complex (**Figures [2C,D](#F2){ref-type="fig"}**). To assess the size of complexes we have analyzed them by size-exclusion chromatography. The elution profiles showed single peaks (not shown) corresponding to the entities with estimated molecular masses of approximately 99.3 kDa and 53.7 kDa for His-HigBA2~Ab~ and HigBA2~Ab~-His complexes, respectively (**Figure [2B](#F2){ref-type="fig"}**). Protein analysis of pooled fractions that corresponded eluted peaks by 15% SDS--PAGE and subsequent gel densitometric analysis showed two bands present in ratio (toxin:antitoxin) of approximately 1.5:1 and 1:1 (**Figure [2B](#F2){ref-type="fig"}**). As the differences in observed complex sizes could have been due to the interference of His-tag, we aimed to confirm the complex size with the tag-less protein complex. To eliminate the probable His-tag effect, we constructed plasmids with cleavable His-tags situated at the N-terminus of HigB2~Ab~ (plasmid pET-His6-TEV-HigB-HigA) or HigA2~Ab~ (plasmid pET-HigB-His6-TEV-HigA). However, the cleavage of His-tag was only efficient for the protein complex with N-terminal His-tag fusion of HigA2~Ab~. Upon removal of His-tag from HigBA2~Ab~ complex, size exclusion chromatography resulted in an entity of approximately 109 kDa (Supplementary Figure [S4](#SM8){ref-type="supplementary-material"}), thus confirming that HigBA2~Ab~ is able to form unusually large complex.

HigB2~Ab~ Toxin Is a Ribonuclease
---------------------------------

We have demonstrated previously, that HigB1~Ab~ toxin from *higBA1*~Ab~ system (named as *higBA*~Ab~ in the previous research) when expressed in *E. coli* caused degradation of cellular RNAs and inhibited translation by impairing the incorporation of protein synthesis precursor, therefore suggesting that it might act as a ribonuclease ([@B29]). To investigate whether HigB2~Ab~ possesses a ribonuclease activity *in vitro*, we have purified recombinant His-HigB2 toxin from His-HigBA2~Ab~ complex and tested whether it is able to degrade *A. baumannii* total RNA as well as RNA with known secondary structure such as *E. coli* 5S rRNA and tRNA. HigB2~Ab~ toxin efficiently degraded total *A. baumannii* RNA in a dose dependent manner, whereas in a complex with HigA2~Ab~ protein its ribonuclease activity was blocked (**Figure [3A](#F3){ref-type="fig"}**). The degrading activity against *E. coli* 5S rRNA was only detected using high concentrations of HigB2~Ab~ toxin (**Figure [3B](#F3){ref-type="fig"}**), whereas effect against tRNA at the same conditions was negligible, indicating that HigB2~Ab~ toxin more likely targets unstructured RNAs.

![HigB2~Ab~ toxin acts as a ribonuclease. His-HigBA2 protein complex at the concentration of 1 μM and His-HigB2 toxin at the concentrations of 0, 0.25, 0.5, and 1 μM, were incubated with 1.5 μg of total *A. baumannii* RNA **(A)** and with 3 μg of *E. coli* 5S rRNA **(B)** in 10 μl reactions for 30 min at 37°C. The samples were visualized in 1% agarose gel.](fmicb-09-00732-g003){#F3}

HigA2~Ab~ Antitoxin Represses Transcription From *higBA2*~Ab~ Promoter Whereas HigB2~Ab~ Toxin Acts as a Corepressor
--------------------------------------------------------------------------------------------------------------------

Type II TA complexes or single antitoxin proteins have been shown to bind to the operator DNA of their own promoter and negatively autoregulate operon transcription ([@B32]). HigA2~Ab~ has a HTH domain and could bind to DNA alone or in complex with HigB2~Ab~. It is not known how reverse TA systems, where the toxin is the first gene in the operon, regulate their toxin:antitoxin ratio. We looked if an additional promoter could be found for *higA*~Ab~, indicating additional regulation for antitoxin expression. BPROM tool ([@B61]) predicted promoter elements (-10 and -35) upstream the *higBA2*~Ab~ operon and *higA2*~Ab~ coding sequence (**Figure [4A](#F4){ref-type="fig"}**), indicating that besides promoter for the operon, *higA2*~Ab~ might also have an additional promoter. We have tested the activity of these promoters and their regulation by HigBA2~Ab~ complex and HigA2~Ab~ protein. 200 bp DNA fragments containing *higBA2*~Ab~ and *higA2*~Ab~ promoters were cloned upstream of the *gfp* gene (plasmids pPROBE-P*higBA*-gfp and pPROBE-P*higA*-gfp). Promoter activities were measured by following GFP fluorescence upon induction of HigA2~Ab~ antitoxin and HigBA2~Ab~ complex (plasmids pBAD24-HigA, pBAD24-HigBA) in *E. coli*. Promoterless *gfp* (plasmid pPROBE-gfp) was used to assess autofluorescence level of the cells. Induction of HigA2~Ab~ expression strongly repressed the activity of *higBA2*~Ab~ promoter, and the induction of HigBA2~Ab~ complex showed even more pronounced inhibitory effect (**Figure [4C](#F4){ref-type="fig"}**). Putative *higA2*~Ab~ promoter located within the coding sequence of *higB2*~Ab~ gene did not display any activity (**Figures [4B,D](#F4){ref-type="fig"}**). Our results clearly show that *higBA2*~Ab~ operon is transcriptionally autorepressed by its cognate antitoxin HigA2~Ab~, and HigB2~Ab~ toxin acts as a co-repressor. The predicted *higA2*~Ab~ promoter was not functional.

![Analysis of HigBA2~Ab~ interaction with own promoter region. **(A)** Schematic representation of *A. baumannii higBA2*~Ab~ locus. A part of pAB120 plasmid containing *higBA2~Ab~* operon with predicted promoter is presented (not to scale). Predicted promoter DNA sequences (100 bp out of 200 bp cloned to vectors) used for promoter activity assay are shown, predicted --35 and --10 regions (BPROM) and ATG are indicated in bold; **(B--D)** The assessment of activity of predicted *higBA2*~Ab~ operon promoters. Predicted promoter regions of *higBA2*~Ab~ operon and *higA2*~Ab~ gene were cloned into pPROBE vector, placing them upstream the *gfp* gene as described in Section "Materials and Methods". Then pPROBE with respective promoter sequence or lacking any promoter (Promoterless *gfp*) was co-transformed into *E. coli* DJ624Δ*ara* harboring pBAD24 plasmids, with cloned *higBA2*~Ab~ operon or *higA*~Ab~ antitoxin genes under arabinose inducible promoter. After addition of 0.2% arabinose, GFP fluorescence was measured every 30 min, reflecting the effect of induced proteins on the activity of measured promoters. Three independent experiments were performed, error bars indicate standard deviation. AU, arbitrary units.](fmicb-09-00732-g004){#F4}

Expression of *A. baumannii higB2*~Ab~ and *higA2*~Ab~ Genes in Stress Conditions
---------------------------------------------------------------------------------

We have demonstrated that HigB2~Ab~ and HigA2~Ab~ form a strong complex which causes repression of its own operon. We next asked how *higBA2*~Ab~ locus is expressed in *A. baumannii* K60 ([@B48]) under various conditions. We have chosen to investigate growth and stress conditions relevant to those found in clinical environment and within the host: the stationary phase, conditions mimicking the iron deficiency, growth with ethanol and sub-lethal amounts of antibiotics. The expression changes in both *higB2*~Ab~ and *higA2*~Ab~ were evaluated separately by qPCR to see if there are any differences in expression levels which would indicate the presence of separate transcripts. We have found that transcripts of *higB2*~Ab~ and *higA2*~Ab~ genes were more abundant in stationary phase (more than fivefold increase) comparing to the exponential growth conditions (**Figure [5](#F5){ref-type="fig"}**). Interestingly, the iron deficiency caused by the addition of iron chelator 2,2′-bipyridine ([@B13]) to the LB medium resulted in the up to threefold induction of the *higB2*~Ab~ and *higA2*~Ab~ genes (**Figure [5](#F5){ref-type="fig"}**). The presence of ethanol in the media did not have pronounced effect on the gene expression (**Figure [5](#F5){ref-type="fig"}**). We further tested sub-lethal concentrations of antibiotics. As *A. baumannii* strain K60 was highly resistant to several classes of antibiotics \[aminoglycosides, β-lactams, fluoroquinolones, (Supplementary Table [S4](#SM4){ref-type="supplementary-material"})\], we chose antibiotics which exhibited moderate to low MIC (gentamicin MIC 20 μg/mL, rifampicin MIC 3.125 μg/mL). The antibiotics were added at 1/10 of the MIC, as higher concentrations resulted in severe growth impairment. Effect of meropenem was also tested (1/2 of MIC), due to the presence *bla~OXA-72~* gene in the proximity to *higBA2*~Ab~ in pAB120 plasmid. No significant changes in *higBA2*~Ab~ expression were observed for gentamicin or meropenem, but the addition of rifampicin caused a decrease of expression of both genes (**Figure [5](#F5){ref-type="fig"}**). We therefore conclude that *higBA2~Ab~* module could be expressed during stress conditions linked to stationary phase and iron deficiency stress, as well as it could play a role during RNA synthesis inhibition or yet in other unknown conditions. Additionally, since all expression changes were similar for both *higB2*~Ab~ and *higA2*~Ab~, we can expect both genes to be expressed from a single transcript of the whole operon.

![Expression of *A. baumannii higBA2~Ab~* locus during stress conditions. *A. baumannii* clinical strain K60 was grown in LB to exponential phase (OD~600~ = 1) and to stationary phase (blue bars); in conditions mimicking iron deficiency (LB with or without 2,2′-bipyridine) (red bars), in LB with 1 or 2% ethanol added (purple and cyan bars, respectively) and LB with antibiotics (gentamicin, rifampicin, meropenem, in light blue, light red, and light green, respectively) added. The bacteria were collected at OD~600~ = 1, except for stationary phase, where the bacteria were grown for 48 h reaching OD~600~ of 4.5. Total RNA was isolated and RT-qPCR performed to detect the expression of TA genes as described in Section "Materials and Methods". The differences in transcript amounts were evaluated by comparative Ct method (ΔΔCt) using *rpoB* as a house-keeping gene. At least three biological replicas were performed, error bars indicate standard deviation. Statistically significant difference from *tuf* expression, used as a control, is indicated by one asterisk (*t*-test, *p* \< 0.05), or two asterisks (*t*-test, *p* \< 0.005).](fmicb-09-00732-g005){#F5}

The Role of *higBA2*~Ab~ TA System in Stabilization of *Acinetobacter* Plasmids
-------------------------------------------------------------------------------

Toxin-antitoxin modules are known plasmid stabilization factors in bacteria ([@B14]; [@B22]) and their presence on plasmids conferring resistance to clinically important antibiotics may contribute to the persistence and spread of antibiotic resistant strains. We have previously shown that *higBA2*~Ab~ module is widely spread among *A. baumannii* plasmids ([@B48]; [@B64]), therefore we were interested whether it provides stabilization function for cognate plasmid carrying resistance genes, found in clinical *A. baumannii* isolates. For this purpose plasmid pAB120, which originally carries two copies of *bla~OXA-72~* gene conferring resistance to carbapenems (meropenem and imipenem) was purified from clinical *A. baumannii* strain K60 and *higBA2*~Ab~ locus was deleted (Supplementary Figure [S1](#SM5){ref-type="supplementary-material"}). Given that pAB120 plasmid is equipped with another type II TA module, *splTA* ([@B29]; [@B48]), we sought if the latter could be sufficient to supply plasmid stabilization even when *higBA2*~Ab~ was deleted. Therefore, plasmid with deletion of both TA modules was also constructed (Supplementary Figure [S1](#SM5){ref-type="supplementary-material"}). The pAB120Δ*higBA*~Ab~ and pAB120Δ*higBA*~Ab~Δ*splTA*~Ab~ plasmids were transformed into non-pathogenic *Acinetobacter baylyi* strain ADP1, which is known not to contain any plasmids or *higBA* homologs (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Unexpectedly, neither the deletion of *higBA2*~Ab~ locus, nor the elimination of both *higBA2*~Ab~ and *splTA*~Ab~ modules caused any loss of pAB120 variants in *A. baylyi* (not shown). To eliminate the possibility of different plasmid maintenance effects in different *Acinetobacter* species, *A. baumannii* clinical strain K53 was then used as a host (the strain also does not contain any plasmids of known *A. baumannii* replication groups and *higBA* modules ([@B29]; [@B48]; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). pAB120 variants did not show decrease in plasmid retention in *A. baumannii* as well (**Figure [6A](#F6){ref-type="fig"}**). We then analyzed whether *higBA2*~Ab~ locus has an impact on the copy number of pAB120 plasmid. *A. baumannii* strains K53 bearing pAB120 with or without *higBA2*~Ab~ were grown without antibiotic pressure for 24 h and PCN was calculated by qPCR. A slight reduction in PCN was observed, which was statistically significant (**Figure [6A](#F6){ref-type="fig"}**). These results indicate that while *higBA2*~Ab~ and *splTA*~Ab~ are not the main players in stabilization of pAB120 under tested conditions, the deletion of *higBA2*~Ab~ has an impact on its copy number, and could influence plasmid retention in the long run or in different conditions.

![The role of *A. baumannii higBA2*~Ab~ locus in plasmid stabilization. Bacteria containing plasmids were grown in LB without antibiotic pressure, restarting the culture every 12 h. The colony forming units (CFU) of total bacteria and antibiotic resistant bacteria was assessed by serial dilution and plating. At least three independent experiments were performed, error bars indicate standard deviation. **(A)** The effect of *higBA2*~Ab~ deletion on *A. baumannii* pAB120 plasmid maintenance and copy number. Bacteria containing pAB120 variants with or without *higBA2*~Ab~ or both *higBA2*~Ab~ and *splTA*~Ab~ TA system were selected on media containing meropenem. Inside the box: plasmid copy number (PCN) of pAB120 variants with and without *higBA2~Ab~* was calculated after 24 h growth without antibiotic pressure. PCN was calculated as described in Section "Materials and Methods". The experiment was independently repeated 10 times, the difference of PCN between the two strains was statistically significant (*t*-test, *p* \< 0.05); **(B)** Effect of *higBA2*~Ab~ locus in stabilization of unstable plasmid pAcORI^∗^. *Acinetobacter baylyi* containing variants pAcORI^∗^ with and without *higBA2*~Ab~ were selected on gentamicin (pAcORI^∗^ marker).](fmicb-09-00732-g006){#F6}

To be sure if *higBA2*~Ab~ is able to confer stability when introduced into unstable plasmid lacking any stabilizing determinants, we used *higBA2*~Ab~ from pAB120 in additional plasmid stabilization experiments. The *higBA2*~Ab~ locus with its own promoter region was cloned into unstable *Acinetobacter* plasmid pAcORI^∗^, conferring resistance to gentamicin (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). *A. baylyi* ADP1 strain containing plasmid pAcORI^∗^ with *higBA2*~Ab~ locus and plasmid without the TA system were grown without antibiotic pressure and plasmid retention was calculated. Strikingly, in this background the presence of *higBA2*~Ab~ locus on the pAcORI^∗^ plasmid ensured its stability when bacteria were grown for over 80 h (**Figure [6B](#F6){ref-type="fig"}**). This result together with the previous observations of the effect on PCN confirms that *higBA2*~Ab~ module can play a role in plasmid maintenance.

Discussion
==========

The TA modules which are grouped into *higBA* family (*[h]{.ul}ost [i]{.ul}nhibition of [g]{.ul}rowth*) encode a RelE-like toxin and antitoxin that contains a HTH Xre-domain ([@B16]; [@B40]). Toxins of HigB family belong to a large RelE/ParE superfamily consisting of mRNAses such as RelE toxin as well as gyrase poisons such as ParE toxin ([@B1]). Within this superfamily, GP49-domain toxins show low but significant homology to RelE ([@B40]). TA modules containing GP49-domain toxin in all studied cases constitute the reverse type of TA operons where toxin is encoded first and is followed by an antitoxin ([@B12]; [@B50]; [@B29]; [@B58]). Despite being classified as HigB family toxins, the GP49-domain toxins show little similarity to well-studied HigB toxins from *E. coli, Vibrio cholerae, Proteus vulgaris* ([@B65]; [@B7]; [@B8]) as well as to toxins of other TA families of RelE superfamily. HigBA~Ab~ shows only ∼20% sequence identity to other validated TA modules that have GP49-domain toxins and were named as Tad toxins ([@B12]).

pAB120 plasmid-borne HigBA2~Ab~ proteins form strong complex with molecular mass of approximately 100 kDa suggesting that up to eight protein molecules might be present within the oligomer (the predicted molecular masses of HigB2~Ab~ and HigA2~Ab~ proteins are 13.5 and 11.2 kDa, respectively). According to the currently available structural data, the RelE toxin-based TA superfamily TA complexes are known to form heterotrimers (*E. coli* YefM-YeoB, PDB accession: 2A6Q), and most commonly, heterotetramers (*E. coli* DinJ-YafQ, PDB accession: 4Q2U; MqsR-MqsA, PDB accession: 3HI2, *E. coli* RelB-RelE, PDB accession: 4FXE; *Brucella abortus* BrnT-BrnA ([@B21]), *Proteus vulgaris* HigBA ([@B59])\]. In some cases complexes crystallize as more complex oligomeric structures: a so far unique hetero-hexadecameric complex has been observed for ParE2-PaaA2 TA system ([@B63]). ParE-family toxins inhibit DNA replication and despite sharing common fold they are functionally different from RelE-family toxins. Therefore *A. baumannii* HigBA2~Ab~ complex of 100 kDa, the size strongly exceeding that of a heterotetramer, observed in this study might represent one of the most complex oligomeric structures known for RelE family TAs.

Taking into account the organization of *A. baumannii higBA2*~Ab~ module, where toxin gene is located upstream the antitoxin gene, a feature known for a limited number of TAs ([@B7]), the expression of equal amounts of both proteins must be ensured in the cell to avoid a harmful effect of the toxin. According to our observations, equal levels of *higB2*~Ab~ and *higA2*~Ab~ transcripts are produced at the standard growth conditions in *A. baumannii* indicating that TA balance at least at the transcription level is properly preserved. The transcript of the whole operon (spanning both *higB2*~Ab~ and *higA2*~Ab~ genes) could also be detected by qPCR (Armalytė, Unpublished data), whereas an additional promoter for the *higA2*~Ab~ gene was not, indicating that most likely *higBA2*~Ab~ is transcribed as a single transcript. HigA2~Ab~ antitoxin and HigBA2~Ab~ complex autorepressed their own promoter, indicating the transcriptional regulatory mode common to type II TA operons in other bacteria ([@B5]). HigA2~Ab~ antitoxin harbors HTH Xre-like domain, which is present in some antitoxins of type II TAs such as HigA from *Proteus vulgaris*, and has been shown to bind operator sequences which overlap with the promoter region ([@B59]). The more pronounced inhibition by HigBA2~Ab~ complex than by single antitoxin indicates HigB2~Ab~ toxin also takes part in transcriptional autoregulation of the system.

Despite well studied transcriptional regulation for TA systems, the data on their expression *in vivo* in conditions relevant to bacterial lifestyle, in particular to that of pathogenic species, is only beginning to emerge. *A baumannii* represents interesting example to study as it is well adapted to colonize the abiotic (glass, plastic, and metal) and biotic (human skin and mucous membranes) surfaces, withstand prolonged periods of dryness, treatment by disinfectants, antibiotics and nutrient restriction ([@B17]). In the host, *A. baumannii* encounters responses mediated by complement and professional and non-professional phagocytic cells. Among stress factors playing essential role in the host defense is the nutritional immunity exerted by the iron limitation ([@B42]). Our data suggest that stationary growth and iron depletion causes the induction of both toxin and antitoxin genes of *higBA2*~Ab~ module at a similar level, therefore, expression of both components could play a role for *A. baumannii* stress response. This is supported by recent observation that closest homologues of *A. baumannii higBA* in *M. tuberculosis*, Rv2022c-Rv2021c (*higBA2*) and Rv3182-Rv3183 (*higBA3*) are among the strongest stress responsive modules of this pathogen, activated in response to multiple stressors including antibiotics, starvation and low pH ([@B19]). In our study, we found that only rifampicin influenced the expression of *higBA2*~Ab~ by reducing it, which was the opposite effect from that observed for *M. tuberculosis higBA*s. Sub-inhibitory concentrations of antibiotics are known to induce variable gene expression outcomes in bacteria. SOS response is commonly induced, which includes upregulation of stress proteases such as Lon and Clp. Generally they target antitoxins and relieve transcriptional repression of TAs ([@B44]). However, the observations that particular TAs are downregulated after antibiotic exposure indicate that specific inhibition of the activities of the TA promoters could be involved. Type II loci of other human pathogens have been recently shown to transcriptionally respond under stress conditions. *H. pylori hp0893-hp0892* module, which is the most prevalent TA system among *H. pylori* clinical isolates was induced during stationary growth, in the low concentration of iron and nickel as well as in a high concentration of urea, conditions mimicking the host environment, suggesting that this TA gene pair might represent a novel *H. pylori* stress responsive virulence factor ([@B3]). Intracellular pathogen *B. abortus* increased the expression of type II *brnTA* system in the presence of chloramphenicol, H~2~O~2~ and low pH stress ([@B21]). In *S. enterica* type II s*ehAB* module responded to minimal medium and within macrophages ([@B10]), whereas different expression of some toxins of type II systems has been observed inside fibroblasts and epithelial cells ([@B38]).

The induction of bacterial TAs in stress conditions has been attributed to the enhanced degradation of antitoxin by stress peptidases or decreased translation under stress conditions ([@B52]). This, in turn, might result in the derepression of transcription of TA operon to a different level depending on the stress influence on antitoxin proteolysis and translation rates. Therefore, the decrease in antitoxin concentration might result in various different physiological outcomes: the toxin, freed from the complex, could quickly come into action leading to growth reduction, or an increased transcriptional response of TA genes could be induced, led by derepression of the operon. Such a range in TA-mediated outcomes would be beneficial to *A. baumannii* in contributing to its persistence in clinical environment and in sensing the host.

The *higBA*~Ab~ locus, with a few exceptions, is found so far on the *A. baumannii* plasmids, which frequently harbor antibiotic resistance genes coding for carbapenemases OXA-72, OXA-23, and OXA-58 ([@B64]). We found that 67 out of 307 (21.8%) *Acinetobacter* sp. plasmids sequenced to date (GenBank accessed 2018/01/11) had *higBA*~Ab~ TA systems. The location of *higBA*~Ab~ could not be attributed to a certain plasmid replication group or plasmid size (plasmids sizes varied from 7.4 to 121 kb). The high prevalence of these TA systems indicates their easy spread and stable maintenance on the plasmids. The mechanisms responsible for plasmid stabilization in *A. baumannii* are largely unknown ([@B33]) and this study is the first attempt to assess the role of TA systems in *A. baumannii*. Surprisingly, we have shown that despite the ability of *higBA2*~Ab~ module to function as a *bone fide* addiction system by supporting maintenance of unstable plasmid in *Acinetobacter*, it did not play that role for pAB120 plasmid from clinical *A. baumannii* strain, as did not another type II module, carried by the same plasmid. This data suggest that other elements than plasmid-borne post-segregational killing pathway components are responsible for pAB120 stabilization. Among the possible candidates are XerC/XerD sites, which are known to participate in recombinase-based proper resolution of plasmid copies ([@B60]) and are present in pAB120 plasmid in multiple copies as well as in series of *A. baumannii* plasmids of the same replicon type ([@B33]).

Another unexpected observation was the detection of several *higBA*~Ab~ copies in plasmids and *A. baumannii* isolates in the sequence databases. Interestingly, only the less conserved *higBA2*~Ab~ group was detected in that setting, and we were unable to find both groups *higBA*~Ab~ in one isolate or plasmid in the pool of *Acinetobacter* sp. sequences, available to this day. In agreement with this observation we have demonstrated that both groups' antitoxins are able to counteract the toxins. Such counter-activity has been reported for other TA systems ([@B68]). In case of HigBA~Ab~, the two versions might work as counter-addiction modules for each other. The observed duplication of *higBA2*~Ab~ could indicate the ongoing evolution and divergence of the novel TA species.
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